A four year analysis of variation in use of the anti-neutrophil cytoplasmic antibody (ANCA) test as a screening tool for ANCA-associated systemic vasculitis (AAV) in a teaching hospital.

Documenti analoghi

• Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
  di: McLaren, J, et al.
  Pubblicazione: (2001)
• The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting.
  di: McLaren, J, et al.
  Pubblicazione: (2001)
• CONTEXTUALISING QUALITY OF LIFE IN ANCA ASSOCIATED VASCULITIS (AAV)
  di: Basu, N, et al.
  Pubblicazione: (2012)
• Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
  di: Luqmani, R, et al.
  Pubblicazione: (2017)
• Determinants of Poor Quality of Life in ANCA Associated Vasculitis (AAV).
  di: Basu, N, et al.
  Pubblicazione: (2012)